A detailed history of Principal Securities, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 83 shares of TXG stock, worth $1,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Previous 52 59.62%
Holding current value
$1,787
Previous $1.95 Million 17.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$19.45 - $37.37 $602 - $1,158
31 Added 59.62%
83 $1.61 Million
Q1 2024

May 10, 2024

SELL
$36.08 - $54.3 $144 - $217
-4 Reduced 7.14%
52 $1.95 Million
Q4 2023

Feb 07, 2024

BUY
$34.32 - $57.55 $1,921 - $3,222
56 New
56 $3.13 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $2.05B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.